EGFR and cancer: Subsequently, we investigated the impact of depleting ZNRF3 or RNF43 on EGFR clearance at the cell surface in mouse embryonic fibroblasts (MEFs) and human cancer cell lines including APC-mutated colorectal cancer cells.